文献
J-GLOBAL ID:202202257715480880
整理番号:22A0950326
進行性肝線維症患者におけるBMS-986263: 無作為化プラセボ対照第2相試験からの36週間の結果【JST・京大機械翻訳】
BMS-986263 in patients with advanced hepatic fibrosis: 36-week results from a randomized, placebo-controlled phase 2 trial
著者 (12件):
Lawitz Eric J.
(The Texas Liver Institute, University of Texas Health San Antonio, San Antonio, Texas, USA)
,
Shevell Diane E.
(Bristol Myers Squibb, Princeton, New Jersey, USA)
,
Tirucherai Giridhar S.
(Bristol Myers Squibb, Princeton, New Jersey, USA)
,
Du Shuyan
(Bristol Myers Squibb, Princeton, New Jersey, USA)
,
Chen Warner
(Bristol Myers Squibb, Princeton, New Jersey, USA)
,
Kavita Uma
(Bristol Myers Squibb, Princeton, New Jersey, USA)
,
Coste Angie
(The Texas Liver Institute, University of Texas Health San Antonio, San Antonio, Texas, USA)
,
Poordad Fred
(The Texas Liver Institute, University of Texas Health San Antonio, San Antonio, Texas, USA)
,
Karsdal Morten
(Nordic Bioscience, Herlev, Denmark)
,
Nielsen Mette
(Nordic Bioscience, Herlev, Denmark)
,
Goodman Zachary
(Inova Fairfax Hospital, Falls Church, Virginia, USA)
,
Charles Edgar D.
(Bristol Myers Squibb, Princeton, New Jersey, USA)
資料名:
Hepatology
(Hepatology)
巻:
75
号:
4
ページ:
912-923
発行年:
2022年
JST資料番号:
T0889A
ISSN:
0270-9139
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)